Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (55)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  3. Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimization

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine

    Scientific Reports, Vol. 12, Núm. 1

  2. Gold Glyconanoparticles Combined with 91–99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors

    Cancers, Vol. 14, Núm. 10

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. A Comparison Between Recombinant Listeria GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for Listeria, Mycobacterium, and Streptococcus

    Frontiers in Immunology, Vol. 12

  2. Glyceraldehyde-3-phosphate dehydrogenase common peptides of listeria monocytogenes, mycobacterium marinum and streptococcus pneumoniae as universal vaccines

    Vaccines, Vol. 9, Núm. 3

2020

  1. Epitopes for Multivalent Vaccines Against Listeria, Mycobacterium and Streptococcus spp: A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase

    Frontiers in Cellular and Infection Microbiology, Vol. 10

2019

  1. Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma

    OncoImmunology, Vol. 8, Núm. 2

2017

  1. Antiretroviral treatment of HIV-2 infection

    Future Virology, Vol. 12, Núm. 8, pp. 461-472

  2. Dendritic cell therapy in melanoma

    Annals of Translational Medicine, Vol. 5, Núm. 19, pp. 1-9

  3. GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination

    Oncotarget, Vol. 8, Núm. 33, pp. 53916-53934

  4. Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma

    Nanoscale, Vol. 9, Núm. 30, pp. 10721-10732

  5. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  6. Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)

    Annals of Translational Medicine, Vol. 5, Núm. 19

2016

  1. Biomarker tools to design clinical vaccines determined from a study of annual listeriosis incidence in northern Spain

    Frontiers in Immunology, Vol. 7, Núm. NOV

  2. Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma

    Oncotarget, Vol. 7, Núm. 13, pp. 16855-16865

  3. Pregnancy vaccination with gold glyco-nanoparticles carrying Listeria monocytogenes peptides protects against listeriosis and brain- and cutaneous-associated morbidities

    Nanomaterials, Vol. 6, Núm. 8